Gaithersburg, MD, United States of America

Carlos Chavez

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 13.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019-2023

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Carlos Chavez

Introduction

Carlos Chavez is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of medical research, particularly in the development of innovative treatments for various diseases. With a total of 4 patents to his name, Chavez continues to push the boundaries of scientific discovery.

Latest Patents

Chavez's latest patents include groundbreaking work on Anti-B7-H1 antibodies for treating tumors. This patent outlines methods for treating B7-H1-expressing tumors by administering an effective amount of MEDI4736 or an antigen-binding fragment thereof. Another significant patent focuses on Anti-PAD4 autoantibodies as clinical response biomarkers for the treatment of rheumatoid arthritis. This disclosure relates to the use of anti-PAD4 autoantibodies as a clinical biomarker for rheumatoid arthritis (RA) treatment, providing an assay to detect these autoantibodies, along with assay kits and computer-implemented diagnostic methods.

Career Highlights

Chavez is currently employed at MedImmune Limited, where he collaborates with other talented professionals in the field. His work has been instrumental in advancing therapeutic options for patients suffering from complex diseases.

Collaborations

Some of his notable coworkers include Meina Liang and Rajesh Narwal. Together, they contribute to the innovative research environment at MedImmune Limited.

Conclusion

Carlos Chavez exemplifies the spirit of innovation in the medical field through his patents and collaborative efforts. His work not only enhances our understanding of disease treatment but also paves the way for future advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…